Expert Insights
Thierry Passeron, MD, PhD: Latest Advances in Medical Therapies for Vitiligo
It’s an exciting moment in the medical treatment of vitiligo, according to Dr. Thierry Passeron, professor and chair of the dermatology department at the Université Côte d’Azur in Nice, France. Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, interviewed Dr. Passeron about the latest medical therapies including what’s currently available and what’s in development. Hear what Dr. Passeron thinks about the data from phase 2 studies on oral JAK inhibitors for widespread vitiligo. Plus if you’re prescribing ruxolitinib for repigmentation, find out the key message that Dr. Passeron says you need to share with your patients.
